Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?Published in:Therapeutic Advances in Hematology, 2018, v. 9, n. 6, p. 135, doi. 10.1177/2040620718774268By:Tasian, Sarah KPublication type:Article
Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia.Published in:Therapeutic Advances in Hematology, 2018, v. 9, n. 6, p. 149, doi. 10.1177/2040620718774258By:Morfini, Massimo;Gherardini, StefanoPublication type:Article